Prophylactic administration of Withania somnifera extract increases host resistance in Listeria monocytogenes infected mice

International Immunopharmacology

Volumn 6, Issue 10, 2006, Pages 1535-1542

  Teixeira, Silvia T ^a   Valadares, Marize C ^a,b   Gonçalves, Shirley A ^a   de Melo, Adriana ^a   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Haematopoiesis; Interferon gamma; Listeria monocytogenes; Withania somnifera L.

Indexed keywords

COLONY STIMULATING FACTOR; GAMMA INTERFERON; WITHANIA SOMNIFERA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BONE MARROW; BONE MARROW SUPPRESSION; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; LISTERIA MONOCYTOGENES; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; SURVIVAL;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; SPLEEN; WITHANIA;

EID: 33747211404     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.03.016     Document Type: Article

References (44)

1. Indian Pharmacopoeia 1985. Appendix 3:3:10, p. 69.
2. Mishra L.C., Singh B.B., and Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev 54 (2000) 334-346
3. Kaur K., Rani G., Widodo N., Nagpal A., Taira K., Kaul S.C., et al. Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chem Toxicol 42 (2004) 2015-2020
4. Mohanty I., Arya D.S., Dinda A., Talwar K.K., Joshi S., and Gupta S.K. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 94 (2004) 184-190
5. Khajuria R.K., Suri K.A., Gupta R.K., Satti N.K., Amina M., Suri O.P., et al. Separation, identification, and quantification of selected withanolides in plant extracts of Withania somnifera by HPLC-UV (DAD)-positive ion electrospray ionisation-mass spectrometry. J Sep Sci 27 (2004) 541-546
6. Dhuley J.N. Adaptogenic and cardioprotective action of Ashwagandha in rats and frogs. J Ethnopharmacol 70 (2000) 57-63
7. al-Hindawi M.K., al-Khafaji S.H., and Abdul-Nabi M.H. Anti-granuloma activity of Iraqi Withania somnifera. J Ethnopharmacol 37 (1992) 113-116
8. Devi P.U. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 34 (1996) 927-932
9. Prakash J., Gupta S.K., and Dinda A.K. Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Nutr Cancer 42 (2002) 91-97
10. Jain S., Shukla S.D., Sharma K., and Bhatnagar M. Neuroprotective effects of Withania somnifera Dunn in hippocampal sub-regions of female albino rat. Phytother Res 15 (2001) 544-548
11. Scartezzini P., and Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71 (2000) 23-43
12. Gupta S.K., Dua A., and Vohra B.P. Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metabol Drug Interact 19 (2003) 211-222
13. Parihar M.S., Chaudhary M., Shetty R., and Hemmani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 11 (2004) 397-402
14. Kuppurajan K., Rajagopalan V., Janaki K., Revathi R., and Venkataraghavan S. Effects of Ashwagandha on the process of ageing on human volunteers. J Res Ayurveda Siddha (1980) 247-258
15. Dhuley J.N. Nootropic-like effect of Ashwagandha (Withania somnifera L.) in mice. Phytother Res 15 (2001) 524-528
16. Sakka M.E., Pavelescu M., and Grigorescu E. Contributions to the pharmacodynamic study of roots of Withania somnifera Dun species of Pakistani origin. Note III: Testing of analgesic activity of dichlormethanic and methanolic extract from Withania somnifera roots. Rev Med Chir Soc Med Nat Iasi 94 (1990) 603-605
17. Davis L., and Kuttan G. Effect of Withania somnifera on cytokine production in normal and cyclophosphamide treated mice. Immunopharmacol Immunotoxicol 21 (1999) 695-703
18. Agarwal R., Diwanya S., Patki P., and Patwardhan B. Studies on immunomodulatory activity of Withania somnifera (Ashwaganda) extracts in experimental immune inflammation. J Ethnopharmacol 67 (1999) 27-35
19. Davis L., and Kuttan G. Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res 21 (2002) 115-118
20. Iuvone T., Esposito G., Capasso F., and Izzo A. Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci 72 (2003) 1617-1625
21. Ziauddin M., Phansalkar N., Patki P.S., Diwanay S., and Patwardhan B.K. Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 50 (1996) 69-76
22. Davis L., and Kuttan G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 17 (2000) 193-200
23. Dhuley J.N. Effect of some Indian herbs on macrophage functions in Ochratoxin A treated mice. J Ethnopharmacol 58 (1997) 15-20
24. Melo A., Justo G.Z., and Queiroz M.L.S. Stimulation of myelopoiesis in Listeria monocytogenes-infected mice by an aggregated polymer isolated from Aspergillus oryzae. Hum Exp Toxicol 20 (2001) 38-45
25. Queiroz M.L.S., Justo G.Z., Valadares M.C., and Pereira-Da-Silva F.R.R. Evaluation of Caesalpinia ferrea extract on bone marrow hematopoiesis in the murine models of listeriosis and Ehrlich ascites tumor. Immunopharmacol Immunotoxicol 23 (2001) 367-382
26. Queiroz M.L.S., Rodrigues A.P.O., Bincoletto C., Figueiredo C.A.V., and Malacrida S. Protective effects of Chlorella vulgaris in lead-exposed mice infected with Listeria monocytogenes. Int Immunopharmacol 3 (2003) 889-900
27. Pamer E.G. Immune responses to Listeria monocytogenes. Nat Rev Immunol 4 (2004) 812-823
28. Eberlin S., doas Santos L.M., and Queiroz M.L.S. Uncaria tomentosa extract increases the number of myeloid progenitor cells in the bone marrow of mice infected with Listeria monocytogenes. Int Immunopharmacol 30 (2005) 1235-1246
29. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 90 (1993) 3725-3729
30. Buchmeier N.A., and Schreiber R.D. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci U S A 82 (1985) 7404-7408
31. Havell E.A. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 143 (1989) 2894-2899
32. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
33. Harty J.T., and Bevan M.J. Specific immunity to Listeria monocytogenes in the absence of IFN γ. Immunity 3 (1995) 109-117
34. Olfert E.D., Cross B.M., and McWilliam AA. Guide to the Care and Use of Experimental Animals vol. 1 (1993), Canadian Council on Animal Care, Ottawa 1
35. Metcalf D. The Bioassay of Colony-Stimulating Factors, The Hematopoetic Colony-Stimulating Factors (1984), Elsevier, Amsterdam 187-212
36. Young A.M., and Cheers C. Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice. Cell Immunol 97 (1986) 227-237
37. Carryn S., Van de Velde S., Van Bambeke F., Mingeot-Leclercq M., and Tulkens P.M. Impairment of growth of Listeria monocytogenes in THP-1 macrophages by granulocyte macrophage colony-stimulating factor: release of tumor necrosis factor-a and nitric oxide. J Infect Dis 189 (2004) 2101-2109
38. Drevets D.A. Dissemination of Listeria monocytogenes by infected phagocytes. Infect Immun 67 (1999) 3512-3517
39. Magee D.M., and Wing E.J. Secretion of colony-stimulating factors by T cell clones: role in adoptive protection against Listeria monocytogenes. J Immunol 143 (1989) 2336-2341
40. Chantry D., Turner M., Brennan F., Kingsbury A., and Feldmann M. Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes. Cytokine 2 (1990) 60-67
41. Bermudez L.E. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages: the role of nitric oxide. Clin Exp Immunol 91 (1993) 277-281
42. Portnoy D.A., Schreiber R.D., Connelly P., and Tilney L.G. Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med 170 (1989) 2141-2146
43. Ouadrhiri Y., Scorneaux B., Sibille Y., and Tulkens P.M. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother 43 (1999) 1242-1251
44. Dhuley J.N. Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 58 (1997) 15-20